Clinical Trial

Lavender (Lavandula Angustifolia) Aromatherapy Inhalation as an Anti-Anxiety Treatment for Pain

Completed
View on ClinicalTrials.gov →
Summary
This clinical trial will assess whether aromatherapy inhalation (especially lavender extract essential oil) can be used as a complementary therapy for anxiety and pain. In this study, outcomes will be measured using the Numeric Rating Scale (NRS) for pain score and State-Trait Anxiety Inventory (STAI) questionnaire to assess state and trait anxiety scores. The two questionnaires above will be used to determine pre-post pain and anxiety scores after exposure. This study's primary research question is "Does linalool in lavender extract essential oil aromatherapy reduce anxiety in patients with pain complaints ?". With the question above, it is hypothesized that linalool can be an anti-anxiety towards pain. The product of aromatherapy will be tested in a GC-MS assay for every substance inside and proving linalool as a key substance. To prove the effect of linalool, this study will compare diffused lavender extract essential oil aromatherapy with a placebo to determine its effect as an anxiety reliever.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-12.
Trial Details
NCT Number NCT07305493
Lead Sponsor Universitas Islam Indonesia
Conditions Anxiety, Pain, Aromatherapy
Enrollment 68 participants
Start Date 2022-10-01
Primary Completion 2023-03-31 (estimated)
Study Completion 2023-05-29 (estimated)
Updated on ClinicalTrials.gov 2026-01-02